What is the difference between hydroxyzine hydrochloride (HCl) and hydroxyzine pamoate for treating anxiety and panic attacks?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: October 21, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Hydroxyzine Hydrochloride vs. Hydroxyzine Pamoate for Anxiety and Panic Attacks

Hydroxyzine hydrochloride and hydroxyzine pamoate are equally effective for treating anxiety and panic attacks, with the primary differences being in their formulations, onset of action, and duration rather than clinical efficacy. 1

Key Differences Between Formulations

  • Hydroxyzine hydrochloride (HCl) has a slightly faster onset of action compared to the pamoate salt, making it potentially more suitable for acute anxiety episodes 1
  • Hydroxyzine pamoate has a slightly longer duration of action, which may be beneficial for sustained anxiety control throughout the day 1, 2
  • Both formulations have similar efficacy profiles for treating anxiety disorders and are used as adjunctive treatments in children, adolescents, and adults 1
  • Both formulations can cause sedation/drowsiness as their primary side effect, which may be more pronounced with the hydrochloride formulation due to its faster absorption 1, 3

Efficacy for Anxiety and Panic Disorders

  • Hydroxyzine (both formulations) has demonstrated efficacy superior to placebo in treating generalized anxiety disorder (GAD), with benefits observed from the first week of treatment 2, 3
  • Hydroxyzine is considered an alternative option for anxiety when SSRIs (the first-line recommendation) are not suitable or as an adjunctive treatment 1, 4
  • In clinical trials, hydroxyzine at 50 mg/day showed significant anxiolytic effects that were maintained throughout treatment periods and after discontinuation without withdrawal symptoms 5, 3
  • Unlike benzodiazepines, hydroxyzine does not cause dependence or withdrawal symptoms, making it potentially advantageous for some patients with anxiety 2, 5

Clinical Considerations When Choosing Between Formulations

  • For acute anxiety or panic attacks requiring faster onset, hydroxyzine hydrochloride may be preferable 1, 6
  • For maintenance therapy or nighttime anxiety with sleep disturbances, hydroxyzine pamoate's longer duration may be beneficial 1
  • Both formulations can be used as chemical restraint in acute agitation situations, though this is not a first-line approach 1
  • Side effect profiles are similar between formulations, with drowsiness being the most common (28% vs 14% with placebo), which typically diminishes with continued use 3

Placement in Treatment Algorithm

  • SSRIs remain the first-line pharmacological treatment for anxiety disorders and panic attacks in both adults and children 1, 4
  • SNRIs are considered second-line options when SSRIs are ineffective or not tolerated 1, 4
  • Hydroxyzine (either formulation) can be considered as an adjunctive treatment for breakthrough anxiety or when sedation is beneficial 1
  • Combination treatment with CBT and an SSRI shows superior efficacy to either treatment alone for anxiety disorders 1, 4

Cautions and Monitoring

  • Both formulations can cause significant sedation, which may affect driving and other activities requiring alertness 1, 3
  • Anticholinergic effects may be problematic in certain populations (elderly, those with glaucoma, prostatic hypertrophy) 1
  • Neither formulation should be used as a primary treatment for severe panic disorder, where SSRIs or SNRIs have stronger evidence 1, 4
  • Monitoring for excessive sedation is important, particularly when initiating therapy or when used in combination with other CNS depressants 1, 3

In clinical practice, the choice between hydroxyzine hydrochloride and pamoate often comes down to practical considerations like dosing schedule preferences, rather than significant differences in efficacy for anxiety and panic attacks 2, 5.

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Hydroxyzine for generalised anxiety disorder.

The Cochrane database of systematic reviews, 2010

Guideline

Treatment Options for Severe Panic Disorder Resistant to Fluoxetine

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Recent clinical trials of hydroxyzine in generalized anxiety disorder.

Acta psychiatrica Scandinavica. Supplementum, 1998

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.